Sirvard M. Kaptryan, FNP-C

Sirvard Kaptryan practices at Community Health Partners in Clovis, California.

Sirvard Kaptryan's NPI, 1841727658, was assigned on May 11, 2017. Sirvard Kaptryan holds California license 95006583.

Sirvard Kaptryan's primary practice is Community Health Partners, at 789 N Medical Center E Dr, Clovis, CA 93611 in Fresno County. The practice phone is (559) 324-4952.

Sirvard Kaptryan's primary practice is Community Health Partners in Clovis, California. Sirvard Kaptryan is also affiliated with Clovis Community Medical Center. The medical group on file is Community Health Partners. Dmand AI also links Sirvard Kaptryan to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sirvard Kaptryan practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Sirvard Kaptryan's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Sirvard Kaptryan is licensed in California.

Dmand AI lists arthritis, hereditary polyneuropathy, joint arthropathy, joint pain, knee injury, lower back pain, lupus and muscle weakness among the conditions Sirvard Kaptryan treats.

CMS data shows 1,390 Medicare services from Sirvard Kaptryan across 4 procedure codes in 2024, for 309 Medicare patients. Medicare paid $48,433 for them. Every service was in an office.

CMS counts 309 Medicare patients who saw Sirvard Kaptryan in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have arthritis, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sirvard Kaptryan's median patient age at 52, with 82% women.

In 2024, Sirvard Kaptryan wrote 1,235 Medicare Part D claims for 285 patients. 81% of them were for generic drugs. CMS names the drug for 1,100 of them, across 21 drugs with 11 or more claims each, at $1,005,899 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Sirvard Kaptryan for performance year 2024, reported as part of a group. Sirvard Kaptryan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sirvard Kaptryan as offering telehealth.

CMS Open Payments shows 284 general payments to Sirvard Kaptryan from 21 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,105.